Page 9 - Best CT (computer tomography) doctors in Turkey: TOP 364 doctors

Education and Specialization:

• Medical Degree: Gazi University Faculty of Medicine (2010)
• Specialization in Orthopedics and Traumatology: S.B. Dışkapı Yıldırım Beyazıt Training and Research Hospital (2017)

Professional Experience:

• Current Position: Orthopedics and Traumatology Specialist at VM Medical Park Pendik Hospital, Istanbul

Areas of Expertise:

• Arthroplasty
• Arthroscopic Joint Surgery
• Trauma Surgery
• Spine Diseases and Surgery
• Tendon Injuries and Repairs
• Extremity Lengthening
• Sports Injuries
• Pediatric Orthopedics

Professional Memberships:

• Turkish Orthopedics and Traumatology Association (TOTBID)
• Turkish Medical Association

Patient Testimonials: Patients have praised Dr. Kasman for his expertise and compassionate care. They highlight his ability to provide thorough explanations and his dedication to patient recovery, making him a highly recommended specialist in his field.

Prof. Cengiz KÖKSAL, M.D.

Cardiovascular Surgery

Areas of Expertise

• Minimally invasive mitral valve repair and replacement
• Off-pump (beating heart) mitral valve surgery
• Minimally invasive aortic valve replacement
• Minimally invasive coronary bypass surgery
• Carotid (neck artery) surgery
• Aesthetic varicose vein surgery
• Non-surgical treatment of arterial/venous aneurysms in the legs

Education

• Primary Education – Afyon, Turkey
• Secondary & High School – Darüşşafaka High School, Graduated as Top of Class
• M.D., Doctor of Medicine – Istanbul University, Istanbul Faculty of Medicine, 1992
• Specialization in Cardiovascular Surgery – Cerrahpaşa Faculty of Medicine, Istanbul University (1992–1998)

Career

• Cardiovascular Surgeon – Süreyyapaşa Chest, Heart and Vascular Diseases Hospital (2001–2007)
  • Contributed to the foundation of the Cardiovascular Surgery Clinic
  • Achieved Associate Professor title in 2005
• Senior Surgeon – Kartal Koşuyolu High Specialization Training and Research Hospital (2007 onward)
  • Appointed Deputy Chief of Cardiovascular Surgery in 2009
  • Clinical Educator from 2011 to 2017
  • Performed over 2,000 open-heart and vascular surgeries
  • Education Supervisor of the Cardiovascular Surgery Clinic (2016–2017)
• Professor – Bezmialem Vakıf University, Faculty of Medicine (2017–2024)
  • Head of Cardiovascular Surgery Department
• Current Position – Medipol University, Medipol Acıbadem Regional Hospital (Since July 2024)

International Training and Grants

• Leonardo da Vinci EU Scholarship Winner, Portugal (2012)
• Advanced trainings in minimally invasive mitral valve surgery (without sternotomy or heart-lung machine) conducted in:
  • Israel, Portugal, United Kingdom, Italy, Germany (2012–2016)

Achievements & Honors

• "Physician of the Year", Ibn Sina 1000th Year Medical Awards (2018)
• Only physician in Turkey authorized to educate and practice off-pump mitral valve repair
• Organizer of annual Mitral Valve Repair Workshops with national and international participation
• President, National Vascular and Endovascular Surgery Association (2016–2018)
• Editor, the most comprehensive vascular surgery textbook published in Turkish

Academic Contributions

• 80+ peer-reviewed international scientific articles
• 75+ national publications
• Authored 4 book chapters

Delivered 

200+ presentations

 in national and international conferences (since 2011)

Prof. Dr. Mehmet Sait Buğdacı is a highly experienced physician specializing in Internal Medicine and Gastroenterology. He completed his medical education and specialty training at Istanbul University Cerrahpaşa Faculty of Medicine and Şişli Etfal Training and Research Hospital. His clinical interests include gastrointestinal diseases, endoscopic procedures, and clinical research. He has contributed to medical education through numerous scientific publications and textbooks and currently sees patients at Central Hospital.

Areas of Interest • Pediatric gastrointestinal surgery • Anorectal malformations and motility disorders • Minimally invasive pediatric surgery • Pediatric colorectal and pelvic floor disorders

Prof. İbrahim Azboy, M.D.

Languages: English, Kurdish, Arabic

Orthopaedics and Traumatology
 

Areas of Expertise and Interest

• Hip & knee arthroplasty (primary, revision, robotic‑assisted)
• Infection prevention & management in joint replacements
• Minimally invasive and joint‑preserving orthopedic surgery
• Sports & trauma-related injuries (e.g. ACL, fractures)
• Osteoarthritis, cartilage damage & osteonecrosis

International Researcher IDs:  

• ORCID: 0000-0003-0926-3029 / Yoksis Researcher ID: 145243 

Education & Training

• 1994–2001: Hacettepe University, Faculty of Medicine
• 2002–2008: Ministry of Health Istanbul Training and Research Hospital
• 2014 & 2017: Hospital for Special Surgery, New York, USA – Knee and Hip Arthroplasty and Arthroscopy Training
• 2016: Rothman Institute, Thomas Jefferson University, Philadelphia, USA – Knee and Hip Arthroplasty and Hip Preserving Surgery Training

Academic & Professional Appointments

• 2021–Present: Professor, Istanbul Medipol University
• 2017–2020: Associate Professor, Istanbul Medipol University
• 2011–2017: Assistant Professor, Dicle University
• 2008–2011: Consultant MD, Şanlıurfa and Balıkesir Military Hospitals

Professional Memberships

• Member of 9 national and international orthopedic associations including:
  AAHKS, SICOT, EHS, KADAD, TOTBID, TOTEK, and TTB

Scientific & Educational Contributions

• Prof. Dr. İbrahim Azboy has authored over 70 internationally and 25 nationally peer-reviewed journal articles, contributed to 4 book chapters and 2 book translations, and presented at 25+ international and 65+ national congresses. He also serves as a reviewer for 13 scientific journals, including JBJS, JOA, SICOT-J, and JORR.

Teaching & Speaking Engagements

• Speaker/trainer in 20+ national courses and congresses on topics such as:
• Hip and knee arthroplasty
• Prosthetic joint infections
• VTE prophylaxis
• Surgical approaches and implant strategies

EDUCATION:

2000 - SSK Okmeydanı Training and Research Hospital, .

1996 - Istanbul University, Istanbul Faculty of Medicine

EXPERIENCE:

2019 - Istanbul Medipol University Pendik Hospital

2017 - 2019 - Private Adatıp Kurtköy Hospital

2005 - 2017 - Private Avicenna Umut Hospital

2003 - 2005 - SSK Yalova Regional Hospital

2002 - 2003 - Kayseri Military Hospital

Education

• 2002 - 2008, Ege University, Bachelor's Degree, Medical Doctor
• 2009 - 2013, Istanbul Bagcilar Training and Research Hospital, Specialization in Cardiology
• 2013 - 2018, Bezm-i Âlem Vakif University, Assistant Professor
• 2018 – 2021, Bezm-i Âlem Vakif University, Associate Professor

Experience

• 2009 - 2013, Istanbul Bagcilar Training and Research Hospital
• 2013, Istanbul Esenler Basaksehir State Hospital
• 2014, Bursa Mustafakemalpasa State Hospital
• 2013 – 2014, Ministry of Health Mehmet Akif Ersoy Hospital
• 2014 – 2016, Mustafakemalpasa State Hospital, Bursa
• 2016 – 2024, Bezm-i Âlem Vakif University
• 2024 – Present, Medipol Acibadem Hospital

Education:

Bachelor's Degree

• Field: Faculty of Medicine
• University: Gazi University
• Years: 2009-2015

PhD/Medical Specialty

• Field: Department of Internal Medicine/Cardiology Department
• University: Mustafa Kemal University
• Years: 2016-2020

Experience:

General Practitioner

• Institution: Kırıkhan Community Health Center
• Years: 2015-2016

Research Assistant Doctor

• Institution: Hatay Mustafa Kemal University Faculty of Medicine Cardiology Department
• Years: 2016-2020

Specialist Doctor

• Institution: Hatay Training and Research Hospital
• Years: 2020-2022

Doctor Academic Staff

• Institution: Hatay Mustafa Kemal University Faculty of Medicine Cardiology Department
• Years: 2022-2024
•  

PROFESSIONAL EXPERIENCE

2011-2012
Erzurum Koprukoyu State Hospital
Department: General Medicine

2012-2017
Istanbul University Cerrahpaşa Medical Faculty
Department: Internal Medicine

06/2017-10/2017
Istanbul Gaziosmanpasa Taksim Training and Research Hospital
Department: Internal Medicine

10/2017-11/2018
Istanbul University Istanbul Medical Faculty
Department: Allergy and Immunology Fellowship

2018/2022
Istanbul University Oncology Institute
Department: Medical Oncology Fellowship

2022-2023
Tekirdag City Hospital
Department: Medical Oncology Specialist

2023-present
Istanbul Medipol University Medipol Bahcelievler Private Hospital
Department: Medical Oncology Assoc. Prof.

EDUCATION

2005-2011
Medical Education
Sivas Cumhuriyet University Medical Faculty, Sivas, Turkey

2012-2017
Internal Medicine
Istanbul University Cerrahpaşa Medical Faculty, Department of Internal Medicine, Istanbul, Turkey

2017-2018
Allergy-Immunology Fellowship
Istanbul University Istanbul Medical Faculty
Department of Internal Medicine, Division of Allergy and Immunology, Istanbul, Turkey

2018-2022
Medical Oncology Fellowship
Istanbul University Oncology Institute, Department of Medical Oncology, Istanbul, Turkey

2022
ESMO Board Certification in Medical Oncology
10th September 2022 in Paris, France.

2023
Medical Oncology Assoc. Prof.
Istanbul Medipol University Department of Medical Oncology, Istanbul, Turkey

INTERNATIONAL CLINICAL TRIALS:

1. Astefania - ROCHE

• Title: A Study Evaluating the Efficacy and Safety of Adjuvant Atezolizumab or Placebo and Trastuzumab Emtansine for Participants With HER2-Positive Breast Cancer at High Risk of Recurrence Following Preoperative Therapy
• Role: Subinvestigator

2. PFİZER

• Title: A Study Of Lorlatinib Versus Crizotinib In First-Line Treatment Of Patients With ALK-Positive NSCLC
• Role: Subinvestigator

3. RECITE - AMGEN

• Title: Study of Romiplostim for Chemotherapy-induced Thrombocytopenia in Adult Subjects With Gastrointestinal, Pancreatic, or Colorectal Cancer
• Role: Subinvestigator

4. NAVIGATE - BAYER

• Title: A Study to Test the Effect of the Drug Larotrectinib in Adults and Children With NTRK-fusion Positive Solid Tumors
• Role: Subinvestigator

5. RUBY - Tesaro (PRA)

• Title: A Phase 3, Randomized, Double-blind, Multicenter Study of Dostarlimab (TSR-042) Plus Carboplatin-paclitaxel Versus Placebo Plus Carboplatin-paclitaxel in Patients With Recurrent or Primary Advanced Endometrial Cancer
• Role: Subinvestigator

6. ENGOT-ov43/GOG-3036 - MSD

• Title: Study of Chemotherapy With Pembrolizumab (MK-3475) Followed by Maintenance With Olaparib (MK-7339) for the First-Line Treatment of Women With BRCA Non-mutated Advanced Epithelial Ovarian Cancer (EOC) (MK-7339-001/KEYLYNK001/ENGOT-ov43/GOG-3036)
• Role: Subinvestigator

7. ASTRA ZENECA

• Title: To Study Clinical Effectiveness and Safety of Olaparib Monotherapy in Metastatic Breast Cancer Patients.
• Role: Subinvestigator

8. ROSY-O - ASTRA ZENECA

• Title: Roll Over StudY for Patients Who Have Completed a Previous Oncology Study With Olaparib
• Role: Subinvestigator
•  

INTERNATIONAL PUBLICATIONS

I. Published journal articles indexed by SCI, SSCI, and AHCI

Weekly Paclitaxel in Classic Kaposi Sarcoma

• Authors: Paksoy, N., Khanmammadov, N., Doğan, İ., Ferhatoğlu, F., Ahmed, M. A., Karaman, S., & Aydiner, A.
• Journal: Medicine, 102(5)

Carboplatin Desensitization in Ovarian Carcinoma

• Authors: Paksoy, N., Khanmammadov, N., Doğan, İ., Ferhatoğlu, F., Yildiz, A., Ak, N., & Aydiner, A.
• Journal: Medicine, 101(45), e31726

High-Dose Chemotherapy for Ewing’s Sarcoma

• Authors: Paksoy, N., Ferhatoglu, F., Dogan, İ., Khanmammadov, N., Celik, A. I., Gulbas, Z., & Başaran, M.
• Journal: Medicine, 101(49), e32213

Multidrug Refractory TFE3(+) Renal Cell Carcinoma

• Authors: Paksoy, Nail, et al.
• Journal: Journal of Oncology Pharmacy Practice, 2022, 28.1: 215-221

Crizotinib Efficacy in NSCLC with MET Alterations

• Authors: Gürbüz, M., Kiliçkap, S., Bilici, A., Karadurmuş, N., Sezer, A., Şendur, M. A. N., ... & Demirkazik, A.
• Journal: Medicine, 101(50), e32368

Clinicopathological Features in ALK Mutant NSCLC

• Authors: Dogan, I., Gurbuz, M., Paksoy, N., Ferhatoglu, F., Vatansever, S., Saip, P., ... & Aydiner, A.
• Journal: Medicine, 101(34)

PSMA-Based Tumor Burden in Prostate Cancer

• Authors: HAS SIMSEK, Duygu, et al.
• Journal: Annals of Nuclear Medicine, 2021, 35.6: 680-690

Atezolizumab in Metastatic Urothelial Carcinoma

• Authors: TURAL, Deniz, et al.
• Journal: European Urology Focus, 2021, 7.5: 1061-1066

Pulmonary Sarcomatoid Carcinoma

• Authors: FERHATOGLU, Ferhat, et al.
• Journal: Oncology Research and Treatment, 2021, 44.11: 590-601

Prognostic Factors in Atezolizumab-Treated Urothelial Carcinoma

• Authors: TURAL, Deniz, et al.
• Journal: International Journal of Clinical Oncology, 2021, 26.8: 1506-1513

Atezolizumab with Chemotherapy in Small Cell Lung Cancer

• Authors: GÜRBÜZ, Mustafa, et al.
• Journal: Journal of Cancer Research and Clinical Oncology, 2022, 1-9

FOLFIRINOX vs. Gemcitabine + Nab-Paclitaxel in Pancreatic Cancer

• Authors: AY, Seval, et al.
• Journal: Journal of Chemotherapy, 2022, 1-7

Trastuzumab Emtansine in Older HER2-Positive Breast Cancer Patients

• Authors: CIL, Ibrahim, et al.
• Journal: Tumori Journal, 2022, 108.1: 19-25

Real-Life Efficacy of Osimertinib in Advanced NSCLC

• Authors: HIZAL, Mutlu, et al.
• Journal: Journal of Cancer Research and Clinical Oncology, 2022, 148.6: 1501-1508

ALK-Positive Cells Percentage and Alectinib Efficacy

• Authors: Hizal, M., Bilgin, B., Paksoy, N., Atcı, M. M., Kahraman, S., Kılıçkap, S., ... & Şendur, M. A. N.
• Journal: Journal of Cancer Research and Clinical Oncology, 149(8), 4141-4148

Real-World Data on Alectinib in ALK-Positive NSCLC

• Authors: Hizal, M., Bilgin, B., Paksoy, N., Kılıçkap, S., Atcı, M. M., Kahraman, S., ... & Şendur, M. A. N.
• Journal: Future Oncology, 18(23), 2573-2582

Prognostic Factors in Metastatic RCC with T790M Mutation

• Authors: Dogan, I., Iribas, A., Paksoy, N., Vatansever, S., & Basaran, M.
• Journal: Journal of Cancer Research and Therapeutics

FLOT Regimen in Metastatic Gastric Cancer

• Authors: Tastekin, D., Paksoy, N., Dogan, I., Ferhatoglu, F., Khanmammadov, N., Bozbey, H. U., & Karabulut, S.
• Journal: Journal of Cancer Research and Therapeutics

Desensitization Protocol in Lenalidomide Hypersensitivity Reactions

• Authors: DEMIR, Semra, et al.
• Journal: Annals of Allergy, Asthma & Immunology, 2019, 123.4: 394-397

Factors Associated with Diagnostic Skin Test Positivity in PPI Hypersensitivity

• Authors: ÖZDEMIR, Seçil Kepil, et al.
• Journal: Allergy, 2019, 74.6: 1187-1190

Efficacy of Capecitabine and Temozolomide in Neuroendocrine Tumors

• Authors: Ünal, Ç., Azizy, A., Karabulut, S., Taştekin, D., Akyıldız, A., Yaşar, S., ... & Sağlam, S.
• Journal: The Oncologist, oyad257

Subsequent Treatments in Hormone-Positive Breast Cancer Progression

• Authors: Karacin, C., Oksuzoglu, B., Demirci, A., Keskinkılıç, M., Baytemür, N. K., Yılmaz, F., ... & Hacıbekiroğlu, İ.
• Journal: BMC cancer, 23(1), 192

Termination of Trastuzumab in HER2-Positive Metastatic Breast Cancer

• Authors: Dogan, I., Aydin, E., Khanmammadov, N., Paksoy, N., Saip, P., & Aydiner, A.
• Journal: Scientific Reports, 13(1), 8779

Long-term Outcomes and Predictors of Recurrence in Node-Negative Early Stage Breast Cancer

• Authors: Dogan, I., Aydin, E., Khanmammadov, N., Paksoy, N., Ferhatoğlu, F., Ak, N., ... & Aydiner, A.
• Journal: Journal of Cancer Research and Clinical Oncology, 1-9

Prognostic Factors Influencing PFS in HER2-Positive Metastatic Breast Cancer

• Authors: Doğan, İ., Paksoy, N., Ak, N., Vatansever, S., Saip, P., & Aydıner, A.
• Journal: European Journal of Breast Health, 19(2), 128

Treatment Efficacy of Ribociclib or Palbociclib plus Letrozole in Metastatic Breast Cancer

• Authors: Kahraman, S., Erul, E., Seyyar, M., Gumusay, O., Bayram, E., Demirel, B. C., ... & Nahit Sendur, M. A.
• Journal: Future Oncology, 19(10), 727-736

Efficacy and Safety of Sorafenib in Adult Metastatic Osteosarcoma Patients

• Authors: Dogan, I., Paksoy, N., & Basaran, M.
• Journal: Journal of Cancer Research and Therapeutics

Single-Agent Temozolomide as Salvage Therapy in Heavily Pretreated Metastatic Sarcoma Patients

• Authors: Dogan, I., Paksoy, N., & Basaran, M.
• Journal: Journal of Cancer Research and Therapeutics

Outcomes and Prognostic Factors in Metastatic Renal Cell Carcinoma with Brain Metastases

• Authors: Dogan, I., Iribas, A., Paksoy, N., Vatansever, S., & Basaran, M.
• Journal: Journal of Cancer Research and Therapeutics

FLOT Regimen in First-Line Treatment of Metastatic Gastric Cancer

• Authors: Tastekin, D., Paksoy, N., Dogan, I., Ferhatoglu, F., Khanmammadov, N., Bozbey, H. U., & Karabulut, S.
• Journal: Journal of Cancer Research and Therapeutics

Prognostic Factors of Perioperative FLOT Regimen in Operable Gastric Cancer

• Authors: Erol, C., Sakin, A., Basoglu, T., Ozden, E., Cabuk, D., Dogan, M., ... & Sendur, M. A. N.
• Journal: [Not specified]

Efficacy and Outcomes of Systemic Chemotherapy in Posttransplant Kaposi Sarcoma

• Authors: Khanmammadov, N., Paksoy, N., Doğan, I., Ferhatoğlu, F., Saip, P., & Aydiner, A.
• Journal: Medicine, 102(39), e35383

Comparison of Second-Line Treatments in Metastatic Renal Cell Carcinoma

• Authors: Pehlivan, M., Paksoy, N., Aydin, E., Basaran, M., & Ekenel, M.
• Journal: Medicine, 102(41), e35245

Toxicity Management and Effectiveness of Regorafenib in Advance GIST Patients: A Real-world Study - Authors: Paksoy, N., Ferhatoğlu, F., Doğan, İ., Khanmammadov, N., Bozbey, H. U., Karabulut, S., & Taştekin, D. - Journal: TURKISH JOURNAL OF ONCOLOGY, 1(1)

Demographic and Clinical Features and Factors Associated with Survival in Patients with Primary Glomerulonephritis: Single Tertiary Center Experience - Authors: Paksoy, N., Trabulus, S., Seyahi, N., & Altiparmak, M. R. - Journal: Namik Kemal Tip Dergisi, 11(1)

Efficacy of Sorafenib in Symptomatic Patients with Pretreated Progressive Desmoid Tumors - Authors: Paksoy, N., Ferhatoglu, F., Dogan, I., Ak, N., Pehlivan, M., Ekenel, M., & Basaran, M.

Nodal Response to Neoadjuvant Chemotherapy is a Better Predictive Factor of Survival Than Miller-Payne Scoring in Breast Cancer - Authors: Ak, Naziye, et al. - Journal: Journal of Oncological Sciences, 7.2: 42-49

Evaluation of Prognostic and Predictive Values of Hemogram Parameters in Patients with Advanced Stage Ovarian Carcinoma - Authors: Ak, Naziye, et al. - Journal: Turkish Journal of Oncology/Türk Onkoloji Dergisi, 2021, 36.4

Identifying Risk Factors Associated with Survival and Drug-Related Toxicities in Imatinib-Resistant Gastrointestinal Stromal Tumor (GIST) Patients Treated with Sunitinib - Authors: Ferhatoglu, F., Karabulut, S., Paksoy, N., & Tastekin, D.

Real-life Outcomes of ROS1 Fusion-positive Metastatic Lung Cancer Patients who were Treated with Crizotinib - Authors: Dogan, İ., Khanmammadov, N., Paksoy, N., Ferhatoglu, F., Aydın, E., Vatansever, S., & Aydine, A. - Journal: TURK ONKOLOJI DERGISI-TURKISH JOURNAL OF ONCOLOGY

Predictors of the acquisition of T790M mutation in EGFR-mutant metastatic lung cancer patients who were treated with EGFR inhibitors - Authors: Dogan, I., Khanmammadov, N., Paksoy, N., Vatansever, S., Saip, P., & Aydıner, A. - Journal: Eurasian Journal of Pulmonology

Laterality of Adrenal Gland Metastasis in Lung Cancer: Results of a Comparative Study - Authors: Ferhatoglu, F., Gagatay, T., Okumus, G., Aydiner, A., Paksoy, N., Ak, N., ... & Saip, P. - Journal: Eurasian Journal of Medical Investigation, 7(2)

Poor Risk Factors Affecting Cancer Patients Infected with Covid-19: A Retrospective Comparative Study from a Pandemic Hospital - Authors: Ferhatoglu, F., Kapağan, T., Paksoy, N., Ak, N., Medetalibeyoğlu, A., Şenkal, N., ... & Vatansever, S. - Journal: Turk Onkoloji Dergisi, 38(1)

Systemic Treatment Outcomes of Progressive Medullary Thyroid Carcinoma from the Registries of a Tertiary Cancer Center - Authors: Ferhatoglu, F., Paksoy, N., & Başaran, M. - Journal: Namik Kemal Tip Dergisi, 10(4)

Evaluation of clinical features and risk factors related to late recurrence (> 5 years) in patients with breast cancer - Authors: Ferhatoglu, F., Aydiner, A., & Paksoy, N. - Journal: Journal of Surgery & Medicine (JOSAM), 6(12)

Assessing the Clinical Impact of Lutetium-177 DOTATATE Peptide Receptor Radionuclide Therapy (PRRT) on Metastatic Neuroendocrine Tumors: A Multicenter Real-World Data from Türkiye

Thesis:

Istanbul University Cerrahpaşa Medical Faculty, Internal Medicine Department PAKSOY, Nail. Demographical, clinical characteristics and survival factors in patients withprimary glomerulonephritis: Cerrahpasa Medical Faculty Experience. (2016)

International Refereed Congress / Symposium Publications in Proceedings (ASCO/ESMO Abstracts)

Prognostic factors influencing progression-free survival in HER2 positive metastatic breast cancer patients who treated with lapatinib and capecitabine combination

• Authors: Dogan, I., Paksoy, N., Ak, N., Vatansever, S., Saip, P., & Aydiner, A. (2022)

Efficacy of regorafenib and 5-fluorouracil-based rechallenge treatment in the third-line treatment of metastatic colorectal cancer: A Turkish oncology group study

• Authors: Şenocak Taşçi, E., Oyan, B., Sonmez, O., Mutlu, A. U., Atcı, M. M., Oner, I., ... & Gulmez, A. (2022)

Long-term outcomes and predictors of recurrence in patients with early-stage node-negative breast cancer

• Authors: Dogan, I., Aydin, E., Paksoy, N., Ferhatoglu, F., Ak, N., Ibis, K., ... & Aydiner, A. (2021)

Efficacy of temozolomide in pretreated patients with metastatic sarcoma

• Authors: Paksoy, N., Dogan, I., Ekenel, M., & Basaran, M. (2021)

Efficacy of sorafenib in symptomatic patients with pretreated progressive desmoid tumors

• Authors: Ferhatoglu, F., Paksoy, N., Dogan, I., Ak, N., Pehlivan, M., Ekenel, M., & Basaran, M. (2021)

Efficacy of sorafenib in heavily pretreated adult patients with metastatic osteosarcoma

• Authors: Paksoy, N., Dogan, I., Ekenel, M., & Basaran, M. (2021)

Outcomes and prognostic factors in metastatic renal cell carcinoma patients with brain metastases

• Authors: Dogan, İ., Iribas, A., Paksoy, N., Ekenel, M., Vatansever, S., & Basaran, M. (2021)

Association of response to first-line chemotherapy with the efficacy of atezolizumab in patients with metastatic urothelial carcinoma

• Authors: Tural, D., Olmez, O. F., Sümbül, A. T., Artac, M., Ozhan, N., Akar, E., ... & Erman, M. (2021)

Safety and survival in adult women with platinum-sensitive relapsed BRCA mutant ovarian cancer: A study of patients in Olaparib Turkey Early Access Program—LynTurk study

• Authors: Esin, E., Ahmed, M. A., Yıldırım, H. Ç., Mandel, N. M., Erdemoglu, E., Sari, M., ... & Paydas, S. (2023)

Atezolizumab in patients with metastatic urothelial carcinoma who have progressed after first-line chemotherapy: Results of real-life experiences

• Authors: Tural, D., Ölmez, Ö. F., Sümbül, A. T., Artaç, M., Özhan, N., Akar, E., ... & Kılıçkap, S. (2021)

Personal Information

Name Surname : Serdar TOKER
Place of Birth - Year :    Istanbul - 1972
Academic Title : Assoc. Dr.
Foreign Language : English

Education

Ege University Faculty of Medicine - Graduation
Sisli Etfal Training and Research Hospital - Specialised
Work Experience

1998 - 2003 Sisli Etfal Training and Research Hospital
2003 - 2004 Kars State Hospital
2004 - 2006 Erzurum Regional Training and Research Hospital
2006 - 2009 Dumlupınar University Faculty of Medicine, Department of Orthopaedics and Traumatology 
2009 - 2010 Research Fellow. Colorado University Denver Healt Centre Rocky Mountain Regional Trauma Centre Department of Orthopaedics and Hand Surgery
2010 - 2016 Necmettin Erbakan University Department of Orthopaedics and Traumatology. Head of Hand Surgery Department
Courses - Seminars and Certificates Received

2013 FESSH (Federation of European Societies for Surgery of the Hand) European Diploma
2015 RMCD Microsurgery Course Course Chair
2015 National Turkish Orthopaedics and Traumatology Congress Speaker
2015 RMCD Congress Speaker
2014 National Turkish Orthopaedics and Traumatology Congress Speaker
2013 - 2014 Rıdvan Ege Hand Surgery Course Instructor
2013 RMCD Microsurgery Course Instructor
2013 RMCD Congress Session Chair
2012 Shoulder Elbow Surgery Course Instructor
2012 Subspeciality Diploma in Hand Surgery
2011 RMCD Microsurgery Course
2009 Ankle Arthroscopy Course
2008 Knee Arthroscopy Course
2005 Ilizarov Applications Course

Dr. Mehmet Tonge is a neurosurgeon with expertise in Stereotactic and Functional Neurosurgery. He specializes in MR Guided Focused Ultrasound, deep brain stimulation, Gamma Knife Radiosurgery, and surgery for movement disorders, pain, and spasticity.

Dr. Tonge has published 32 articles in international and national journals and written 12 book chapters. He has presented 92 oral and poster presentations and delivered 41 invited lectures. He completed a Deep Brain Stimulation Fellowship at Maastricht University and finished the 4-year EANS training cycle. Dr. Tonge is known for his research and clinical work in functional neurosurgery.

EDUCATION:

2015

Uludag University, Ophthalmology

2008

Eskisehir Osmangazi University, Faculty of Medicine

2001

Kırıkkale Science High School, Numerical

EXPERIENCE:

2019 Gazi University Faculty of Medicine Ophthalmology (Vitreo-Retinal Surgery and Medical Retina Fellowship)

2016 SBÜ Zekai Tahir Burak EAH (Retinopathy of Prematurity Fellowship)/

2015 - 2023 Kocaeli Derince Training and Research Hospital

2023 - Medipol University Pendik Hospital

Dr. Omer Burcak Binicier is a gastroenterology specialist with strong medical training. He earned his medical degree at Ege University. He completed his internal medicine and gastroenterology specialization at Dokuz Eylül University Faculty of Medicine. Dr. Binicier has over ten years of clinical experience. He has held key positions at SBÜ Tepecik Training and Research Hospital and İzmir Bayraklı City Hospital. He also gained international experience at Korea University.

Dr. Binicier diagnoses and treats a wide range of gastrointestinal diseases. His expertise includes early colon and stomach cancers, inflammatory bowel diseases, liver and pancreatic disorders, and digestive system cancers. He uses advanced endoscopic techniques such as EMR, ESD, ERCP, and endoscopic ultrasound. He is also skilled in minimally invasive obesity treatments. His clinical skills are built on years of hands-on work in top medical centers.

Assoc. Prof. Atakan Topçu, M.D., is a medical oncologist at Medipol University and Medipol Acıbadem Regional Hospital. He treats solid tumors, including lung, breast, colorectal, gastric, and neuroendocrine cancers. His work also covers targeted therapies, immunotherapy, geriatric oncology, and cancer-related malnutrition, cachexia, and sarcopenia.

He has authored more than 50 peer-reviewed papers. Recent work includes a 2024 Frontiers in Medicine study on geriatric syndromes and a 2023 Future Oncology paper on sarcopenia and anxiety in lung cancer. He has also published on the CONUT score in breast cancer and on malnutrition in HER2-negative metastatic gastric cancer.

Dr. Topçu serves on the Editorial Board of BMC Cancer. He is a member of the Turkish Society of Medical Oncology, ESMO, and the Turkish Geriatrics Society. Education and training: M.D., Uludağ University; residency in Internal Medicine, Marmara University; fellowship in Medical Oncology, Bezmialem Vakıf University.

Education & Expertise

1995 to 2001 | Ege University Faculty of Medicine – Medical Education

2001 to 2006 | Dokuz Eylül University Faculty of Medicine – Internal Medicine Specialization

2008 to 2011 | Göztepe Training and Research Hospital – Gastroenterology Subspecialty

2014 | Ümraniye Training and Research Hospital – Associate Professor of Gastroenterology

2021 | University of Health Sciences – Professor

Professional Experience

2007 | Nusaybin State Hospital – Internal Medicine Specialist (Civil Service Obligation)

2011 to 2014 | Ümraniye Training and Research Hospital – Gastroenterology Specialist

2014 to 2017 | Ümraniye Training and Research Hospital – Associate Professor of Gastroenterology

2017 to 2021 | Health Sciences University – Associate Professor of Gastroenterology

2015 to 2021 | Ümraniye Training and Research Hospital Gastroenterology Clinic – Clinic Chief

2021 to 2022 | University of Health Sciences – Professor of Internal Medicine and Gastroenterology

2015 to 2022 | Genomic Laboratory (GLAB) Coordinator, Istanbul Provincial Health Directorate

2014 to 2021 | Northern Clinics of Istanbul Journal (indexed in WoS and PubMed) – Founding Editor

2021 to Present | Turkish Liver Research Association – Board Member

2022 to Present | Hepatology Bulletin Journal – Editor

2019 to Present | Hepatology Forum Magazine – Editor

2016 to Present | World Journal of Hepatology – Editor

International Experience

1999 | Trainee Doctor, Regional Infectious Diseases Unit, Western General Hospital, Edinburgh, UK

2000 | Trainee Doctor, Cardiology Unit, North Manchester General Hospital, Manchester, UK

2005 | Assistant Doctor, Regional Infectious Diseases Unit, Western General Hospital, Edinburgh, UK

Professional Memberships

Turkish Gastroenterology Association

Turkish Liver Research Association

EASL – European Association for the Study of Liver

APASL – Asian Pacific Association for the Study of Liver

AAAS – American Association for the Advancement of Science

Awards & Recognitions

2013 | Liver Fibrosis Pathways in Chronic Hepatitis B: A Comparative Proteomic Study – Gilead Fellowship Award

2014 | Liver Fibrosis Pathways in Chronic Hepatitis B: A Comparative Proteomic Study – Viral Hepatitis Fight Association Project Support Award

2014 | The Relationship between Spontaneous Seroconversion and Toll-Like Receptor Gene Polymorphism in Hepatitis B Infection – Turkish Gastroenterology Association, Best Poster Second Prize

2015 | Research on Damage Pathways in Liver Tissue in Chronic Hepatitis B: A Comparative Proteomic Study – Turkish Gastroenterology Association, Best Oral Presentation Third Prize

2016 | Investigations of the EGF and Its Receptor EGFR Gene Variants in Ulcerative Colitis – XV Euroasian Congress of Gastroenterology and Surgery, Best Oral Presentation Third Prize

Dr. Ugur Taskin is a specialist in interventional cardiology. He treats conditions such as high cholesterol, heart valve diseases, heart failure, and coronary artery disease. He received his medical degree from Ankara University Faculty of Medicine.

Dr. Taskin worked at Celal Bayar University Faculty of Medicine from 2009 to 2014, where he gained valuable experience. He is a member of the Turkish Society of Cardiology and the Izmir Medical Chamber. These memberships show his dedication to high standards in cardiology.

Dr. Baha Zengel is a general surgeon with expertise in breast, gallbladder, thyroid diseases, and hernia repairs. He graduated from Ege University Faculty of Medicine in 1990. In 2004, he earned a doctorate in Basic Oncology from Dokuz Eylül University. He became an Associate Professor of General Surgery in 2014 through the Inter-University Board.

Dr. Zengel is skilled in advanced surgical procedures. His experience includes skin and breast-conserving mastectomy, oncoplastic breast surgery, laparoscopic cholecystectomy, sentinel lymph node biopsy, and ROLL/SNOLL techniques. He has held important positions at Izmir Bozyaka Training and Research Hospital, including Education Officer.

He is a member of several professional associations. He serves on the Board of Directors of the Aegean Region Surgery Association and is a founding board member of the Basic Oncology Association.

Prof. Selin Kapan has been a Professor of General Surgery since 2017. She is currently with Istanbul Aydın University, Faculty of Medicine, Department of General Surgery (2022–present). She previously worked at Bakırköy Dr. Sadi Konuk Training and Research Hospital as a Specialist and Associate Professor. She also served as Educational and Administrative Supervisor at Kanuni Sultan Süleyman Training and Research Hospital. In addition, she was Medical Coordinator and General Surgeon at Istanbul Surgery Hospital.

She has authored or co-authored more than 50 peer-reviewed papers. Her research covers hernia repair, perianal fistula, pilonidal disease, hepatic hydatid disease, laparoscopic surgery, and gastrointestinal surgery. Her work has been published in journals such as Digestive Surgery, Hernia, Techniques in Coloproctology, and the Journal of Gastrointestinal Surgery. She is a member of the Turkish Surgical Association, the National Trauma and Emergency Surgery Association, the Hernia Society, the Turkish HPB Surgery Association, the Stem Cell and Cellular Therapies Association, and the Gastroesophageal Reflux Association.

Dr. Zuhal Cakmak Peksen is a Family Medicine Specialist since 2017. She earned her MD from Çukurova University in 2010. She completed specialty training at Yüzüncü Yıl University between 2013 and 2017. She is currently studying for a bachelor’s degree in Health Management at Anadolu University (2024–present).

She has 15 years of clinical practice (2010–2025) across 8 institutions. Her experience includes research in Family Medicine (2013–2017) and work at several Family Health Centers. Since 2020, she has served at TOKİ Avrupa Family Health Center in Gaziosmanpaşa, Istanbul.